A physician emphasized how emotional support, reliable health information and caregiver involvement can encourage men to take a more proactive approach to prostate cancer screening and care.
|Articles|March 21, 2011
- Spring 2011
- Volume 10
- Issue 1
Videos from Yoga Bear
Yoga videos from Yoga Bear, a nonprofit organization that offers yoga community to cancer patients and survivors.
Advertisement
Yoga Bear, a national non-profit organization, is dedicated to promoting more opportunities for wellness and healing to the cancer community through the practice of yoga.
The organization features community, information and videos about yoga, including the ones listed below at
Articles in this issue
over 15 years ago
Blog: A do-it-yourself treatment program for cancer survivorsover 15 years ago
Blog: Hair, Glorious Hairover 15 years ago
Words of Wisdomover 15 years ago
Chilling Hair Newsover 15 years ago
Herb Could Work Against Advanced Breast Cancerover 15 years ago
JourneyForward.orgover 15 years ago
Predicting Colorectal Cancer Recurrenceover 15 years ago
Transplants More Effective for Young Adults with AMLover 15 years ago
Letters From Our Readersover 15 years ago
Cancer: The Change I CherishAdvertisement
Related to this article
After a blood cancer diagnosis, a survivor reflects on the close friends who let her be herself and asks whether she is the kind of friend she once needed.
From a new chemotherapy combination to the first RAS-targeted pill, here's what five years of pancreatic cancer approvals mean for patients.
Dr. Hope S. Rugo explains what KEYNOTE-B49 found about adding Keytruda to chemotherapy for PD-L1-positive, HR-positive, HER2-negative breast cancer.
A new trial will test whether a set course of Brukinsa plus sonrotoclax, which target two pathways that drive hairy cell leukemia, can offer an alternative to chemotherapy.
In the phase 2 MASTERPLAN trial, adding SBRT to chemotherapy lowered the rate of cancer returning near the pancreas from 52.0% to 20.2% at one year.
Dr. Saum Ghodoussipour of Rutgers Cancer Institute answers top searched bladder cancer questions, from treatment and surgery side effects to sex and work.
Three phase 3 prostate cancer results from ESMO 2026 cover long-term survival with abiraterone in metastatic disease, Erleada before and after surgery, and an update on Truqap for PTEN-deficient cancer.
Advertisement
Advertisement
Trending on CURE
1
Precision Radiation Cuts 1-Year Pancreatic Cancer Recurrence to 20.2%
2
3 Prostate Cancer Results From ESMO 2026 Patients Should Know
3
Urologic Oncologist Answers Top Searched Questions in Bladder Cancer
4
The Breast Cancer Test Many Patients Don’t Know to Ask For
5